ID: ALA1208931

Max Phase: Preclinical

Molecular Formula: C20H19NO2

Molecular Weight: 305.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CCNC(=O)c2ccc3ccccc3c2)cc1

Standard InChI:  InChI=1S/C20H19NO2/c1-23-19-10-6-15(7-11-19)12-13-21-20(22)18-9-8-16-4-2-3-5-17(16)14-18/h2-11,14H,12-13H2,1H3,(H,21,22)

Standard InChI Key:  UYDBNSATRIFACE-UHFFFAOYSA-N

Associated Targets(Human)

Dynamin-1 215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.38Molecular Weight (Monoisotopic): 305.1416AlogP: 3.82#Rotatable Bonds: 5
Polar Surface Area: 38.33Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.89CX LogD: 3.89
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: -0.74

References

1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S..  (2010)  Synthesis of potent chemical inhibitors of dynamin GTPase.,  20  (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092]

Source